申请人:Merck Sharp & Dohme Corp.
公开号:US20160176884A1
公开(公告)日:2016-06-23
The present invention is directed to processes for preparing beta 3 agonists of Formula (I) and Formula (II) and their intermediates. The beta 3 agonists are useful in the treatment of certain disorders, including overactive bladder, urinary incontinence, and urinary urgency.